Business news and discussion on TalkFuse.
CEO turned informant: How the FDA built a case against executives promising cheap medications
The FDA’s investigation into CANARX grew from scrutiny of ScriptSourcing, a Florida company that marketed imported prescription medicines to employer health plans. Its chief executive, Gary Becker, became a government co-operating witness and supplied information about CANARX and its executives, helping build a case over alleged illegal drug imports.
An affidavit by FDA investigator Dustin Dobbs says ScriptSourcing had been under scrutiny since at least 2022 and describes two alleged patient-harm incidents involving medicines it sourced, including misbranded Mounjaro and a counterfeit drug. A spreadsheet provided by ScriptSourcing recorded about 16,549 prescription medicines dispensed through financial dealings with CANARX from 2021 to 2026. The affidavit also cites recorded calls in which John and Bob Howard allegedly discussed import routes and their understanding that the medicines could not legally enter the US; one shipment under preparation included Neupro, used for Parkinson’s disease and restless legs syndrome.
In short
- ScriptSourcing’s CEO became a co-operating witness in the FDA’s CANARX investigation.
- Records showed about 16,549 prescriptions dispensed through dealings with CANARX.
- The affidavit describes alleged patient harm and recorded calls about import routes.
Steelman: both sides, in good faith
The strongest fair case each way — we don't pick a winner.
The case for
The investigation may be justified if the evidence shows executives knowingly arranged illegal imports and patients faced risks from misbranded or counterfeit medicines. Co-operating witnesses, records and recorded calls can help authorities establish responsibility and protect patients, especially where medicines are supplied at scale.
The case against
The allegations still need to be proved, and a co-operating executive may have incentives that warrant careful scrutiny. The reported incidents and shipment records do not by themselves establish that CANARX executives caused patient harm or that every medicine supplied was unsafe; enforcement should distinguish proven misconduct from untested claims and preserve fair process.
Explained simply
CANARX and ScriptSourcing are companies involved in arranging prescription medicines for employer health plans. ScriptSourcing, based in Florida, came under FDA scrutiny over medicines it sourced, including reports of a mislabelled Mounjaro product and a counterfeit drug.
The FDA is the US agency that oversees medicines and investigates suspected violations of drug-import rules. ScriptSourcing chief executive Gary Becker became a co-operating witness and provided information about CANARX and its executives, John and Bob Howard.
The case concerns whether medicines were brought into the United States illegally and whether patients were put at risk. The reported dealings involved thousands of prescriptions, making the investigation relevant to patients, employers and the oversight of medicines supplied through health plans.